Development

Feliza Mirasol is the science editor for 

Articles

Twist Bioscience now offers its Express Genes rapid gene synthesis service at its Wilsonville, Ore., manufacturing facility.

Twist Bioscience Launches Gene Synthesis Service

The agreement states that Orbit will implement its bead-based peptide display engine to discover peptide leads specific to targets related to specific tumors.

Orano Med and Orbit Discovery Enter Collaboration for New Novel Targeted Radioligand Therapies 

The collaboration partner for Willow is focused on more sustainable methods to manufacture intermediates and APIs at reduced cost and less waste, in addition to looking for Willow’s expertise in developing and scaling key ingredients.

Willow Biosciences Announces Collaboration with Biopharma Company 

Camena Bioscience has completed $10 million in Series A financing on the back of growing demand for DNA synthesis.

Camena Bioscience Raises $10 Million to Pursue DNA Synthesis Technology

Grant Playter is the Assistant Editor for 

The new excipients manufacturing facility is expected to be completed in 2025.

Croda Pharma Breaks Ground on Excipients Manufacturing Facility

Cynthia A. Challener, PhD, is a contributing editor to BioPharm International.

When one is using continuous hot-melt extrusion to enhance solubility, process control is essential.

Addressing Poorly Soluble APIs with Continuous Hot-Melt Extrusion

Curia is collaborating with Corning to advance biopharmaceutical continuous-flow development and manufacturing programs.

Curia and Corning Collaborate to Advance Biopharmaceutical Continuous-Flow Development

This self-emulsifying system improves the miscibility and dispersibility of formulations in aqueous environments and may improve API solubility.

SuspendIt Anhydrous Introduced as New Compounding Base

Epinephrine is a critical medication used during life-threatening conditions that can affect any age and any person. 

Spectrum Laboratory Products Issues Recall of Epinephrine USP Bulk API Due to Discoloration

Biotech startup, Cradle, has raised $5.4 million in seed funding with an AI-enabled design platform that allows for the synthetic building of cell factories to produce proteins.

API Synthesis and Manufacturing, Large Molecule